4-Substituted Thieno[3,2-d]pyrimidines as Dual-Stage Antiplasmodial Derivatives.
Saved in:
| Title: | 4-Substituted Thieno[3,2-d]pyrimidines as Dual-Stage Antiplasmodial Derivatives. |
|---|---|
| Authors: | Lagardère P; Institut des Biomolécules Max Mousseron, UMR 5247, CNRS, Université de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, 34293 Montpellier, France., Mustière R; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, 13385 Marseille, France., Amanzougaghene N; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, 75013 Paris, France., Hutter S; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, 13005 Marseille, France., Franetich JF; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, 75013 Paris, France., Azas N; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, 13005 Marseille, France., Vanelle P; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, 13385 Marseille, France.; Service Central de la Qualité et de l'Information Pharmaceutiques, AP-HM, Hôpital Conception, 13005 Marseille, France., Verhaeghe P; CHU de Nîmes, Service de Pharmacie, 30029 Nîmes, France.; LCC-CNRS, Université de Toulouse, CNRS UPR 8241, UPS, 31400 Toulouse, France., Primas N; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, 13385 Marseille, France.; Service Central de la Qualité et de l'Information Pharmaceutiques, AP-HM, Hôpital Conception, 13005 Marseille, France., Mazier D; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, 75013 Paris, France., Masurier N; Institut des Biomolécules Max Mousseron, UMR 5247, CNRS, Université de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, 34293 Montpellier, France., Lisowski V; Institut des Biomolécules Max Mousseron, UMR 5247, CNRS, Université de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, 34293 Montpellier, France. |
| Source: | Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2022 Jul 01; Vol. 15 (7). Date of Electronic Publication: 2022 Jul 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35890119 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 4-Substituted Thieno[3,2-d]pyrimidines as Dual-Stage Antiplasmodial Derivatives. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lagardère+P%22">Lagardère P</searchLink>; Institut des Biomolécules Max Mousseron, UMR 5247, CNRS, Université de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, 34293 Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Mustière+R%22">Mustière R</searchLink>; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, 13385 Marseille, France.<br /><searchLink fieldCode="AU" term="%22Amanzougaghene+N%22">Amanzougaghene N</searchLink>; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, 75013 Paris, France.<br /><searchLink fieldCode="AU" term="%22Hutter+S%22">Hutter S</searchLink>; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, 13005 Marseille, France.<br /><searchLink fieldCode="AU" term="%22Franetich+JF%22">Franetich JF</searchLink>; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, 75013 Paris, France.<br /><searchLink fieldCode="AU" term="%22Azas+N%22">Azas N</searchLink>; Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, 13005 Marseille, France.<br /><searchLink fieldCode="AU" term="%22Vanelle+P%22">Vanelle P</searchLink>; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, 13385 Marseille, France.; Service Central de la Qualité et de l'Information Pharmaceutiques, AP-HM, Hôpital Conception, 13005 Marseille, France.<br /><searchLink fieldCode="AU" term="%22Verhaeghe+P%22">Verhaeghe P</searchLink>; CHU de Nîmes, Service de Pharmacie, 30029 Nîmes, France.; LCC-CNRS, Université de Toulouse, CNRS UPR 8241, UPS, 31400 Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Primas+N%22">Primas N</searchLink>; Aix Marseille Univ, CNRS, ICR UMR 7273, Equipe Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, 13385 Marseille, France.; Service Central de la Qualité et de l'Information Pharmaceutiques, AP-HM, Hôpital Conception, 13005 Marseille, France.<br /><searchLink fieldCode="AU" term="%22Mazier+D%22">Mazier D</searchLink>; Centre d'Immunologie et des Maladies Infectieuses (CIMI), INSERM, CNRS, Sorbonne Université, 75013 Paris, France.<br /><searchLink fieldCode="AU" term="%22Masurier+N%22">Masurier N</searchLink>; Institut des Biomolécules Max Mousseron, UMR 5247, CNRS, Université de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, 34293 Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Lisowski+V%22">Lisowski V</searchLink>; Institut des Biomolécules Max Mousseron, UMR 5247, CNRS, Université de Montpellier, ENSCM, UFR des Sciences Pharmaceutiques et Biologiques, 34293 Montpellier, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238453%22">Pharmaceuticals (Basel, Switzerland)</searchLink> [Pharmaceuticals (Basel)] 2022 Jul 01; Vol. 15 (7). <i>Date of Electronic Publication: </i>2022 Jul 01. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101238453 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1424-8247 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214248247%22">14248247 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceuticals (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35890119 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/ph15070820 Languages: – Code: eng Text: English Titles: – TitleFull: 4-Substituted Thieno[3,2-d]pyrimidines as Dual-Stage Antiplasmodial Derivatives. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lagardère P – PersonEntity: Name: NameFull: Mustière R – PersonEntity: Name: NameFull: Amanzougaghene N – PersonEntity: Name: NameFull: Hutter S – PersonEntity: Name: NameFull: Franetich JF – PersonEntity: Name: NameFull: Azas N – PersonEntity: Name: NameFull: Vanelle P – PersonEntity: Name: NameFull: Verhaeghe P – PersonEntity: Name: NameFull: Primas N – PersonEntity: Name: NameFull: Mazier D – PersonEntity: Name: NameFull: Masurier N – PersonEntity: Name: NameFull: Lisowski V IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2022 Jul 01 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 1424-8247 Numbering: – Type: volume Value: 15 – Type: issue Value: 7 Titles: – TitleFull: Pharmaceuticals (Basel, Switzerland) Type: main |
| ResultId | 1 |